Drugs / GW870086
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT01381445 | Apr → Jul 2011 | atopic eczema | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT01160003 | Jul → Nov 2010 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT00549497 | Sep 2007 → Jan 2008 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT00483899 | Oct 2005 → Dec 2006 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT01299610 | Dec 2010 → Mar 2011 | atopic eczema | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT01245426 | Dec 2010 → Jul 2011 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00945932 | Jul → Dec 2009 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 2 | NCT00857857 | Feb → Nov 2009 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GW870086 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01381445 ↗ |
| Known as | GW870086X | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01160003 ↗ |
| Action | Activate | “GW870086X is a potent glucocorticoid agonist in human in vitro functional assays” NCT01160003 ↗ |
| Modality | Small molecule | — CHEMBL4297388 ↗ |
| Route | Inhaled | “Subjects will inhale 0.25 or 1.5 mg/inhalation GW870086X for four times” NCT00483899 ↗ |